JP2003529608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003529608A5 JP2003529608A5 JP2001572544A JP2001572544A JP2003529608A5 JP 2003529608 A5 JP2003529608 A5 JP 2003529608A5 JP 2001572544 A JP2001572544 A JP 2001572544A JP 2001572544 A JP2001572544 A JP 2001572544A JP 2003529608 A5 JP2003529608 A5 JP 2003529608A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- immunostimulatory
- composition
- protein
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020001507 fusion proteins Proteins 0.000 description 26
- 102000037865 fusion proteins Human genes 0.000 description 26
- 230000003308 immunostimulating effect Effects 0.000 description 21
- 210000004443 dendritic cell Anatomy 0.000 description 13
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 11
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 230000024932 T cell mediated immunity Effects 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000021633 leukocyte mediated immunity Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19350400P | 2000-03-30 | 2000-03-30 | |
| US60/193,504 | 2000-03-30 | ||
| PCT/US2001/010515 WO2001074855A2 (en) | 2000-03-30 | 2001-03-30 | Compositions and methods for dendritic cell-based immunotherapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003529608A JP2003529608A (ja) | 2003-10-07 |
| JP2003529608A5 true JP2003529608A5 (enExample) | 2008-05-22 |
| JP5110674B2 JP5110674B2 (ja) | 2012-12-26 |
Family
ID=22713907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001572544A Expired - Fee Related JP5110674B2 (ja) | 2000-03-30 | 2001-03-30 | 樹状細胞に基づく免疫治療のための組成物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7060279B2 (enExample) |
| EP (1) | EP1272633B1 (enExample) |
| JP (1) | JP5110674B2 (enExample) |
| AT (1) | ATE507295T1 (enExample) |
| AU (2) | AU2001247919B2 (enExample) |
| CA (1) | CA2403964C (enExample) |
| CY (1) | CY1111718T1 (enExample) |
| DE (1) | DE60144516D1 (enExample) |
| DK (1) | DK1272633T3 (enExample) |
| ES (1) | ES2362715T3 (enExample) |
| NZ (1) | NZ522066A (enExample) |
| PT (1) | PT1272633E (enExample) |
| WO (1) | WO2001074855A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7198920B1 (en) | 1999-01-29 | 2007-04-03 | Corika Corporation | HER-2/neu fusion proteins |
| US7229623B1 (en) | 2000-08-03 | 2007-06-12 | Corixa Corporation | Her-2/neu fusion proteins |
| US7413869B2 (en) * | 2002-04-05 | 2008-08-19 | Dendreon Corporation | Method for determining potency of antigenic presenting cell based vaccines |
| CA2481509A1 (en) * | 2002-04-11 | 2003-10-23 | Suzanna Tatarewicz | Her-2 receptor tyrosine kinase molecules and uses thereof |
| WO2004111075A2 (en) | 2003-03-05 | 2004-12-23 | Dendreon Corporation | Alternative reading frame polypeptides for treatment |
| US7737253B2 (en) * | 2006-06-16 | 2010-06-15 | Bresagen, Inc. | Human cancer stem cell culture compositions comprising Erbb2 variants and methods of use thereof |
| US7972602B2 (en) * | 2006-08-11 | 2011-07-05 | Dendreon Corporation | Promiscuous HER-2/Neu CD4 T cell epitopes |
| US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| US8309096B2 (en) | 2007-01-15 | 2012-11-13 | Glaxosmithkline Biologicals S.A. | Fusion protein |
| PT2118128E (pt) * | 2007-01-15 | 2013-01-29 | Glaxosmithkline Biolog Sa | Proteínas de fusão compreendendo os antigénios de rejeição tumoral ny-eso-1 e lage-1 |
| EP2118128B1 (en) * | 2007-01-15 | 2012-11-07 | GlaxoSmithKline Biologicals SA | Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1 |
| CA2682661C (en) * | 2007-03-22 | 2017-03-14 | Dendreon Corporation | Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity |
| KR20140103122A (ko) * | 2011-11-17 | 2014-08-25 | 넨키 인스티튜트 오브 익스페리멘탈 바이올로지 | 신경교종을 치료하기 위한 조성물 및 방법 |
| EP2777711A1 (en) * | 2013-03-11 | 2014-09-17 | Icon Genetics GmbH | Her2/Neu cancer vaccine |
| WO2017096247A1 (en) | 2015-12-04 | 2017-06-08 | Mayo Foundation For Medical Education And Research | Methods and vaccines for inducing immune responses to multiple different mhc molecules |
| KR102594083B1 (ko) | 2020-07-07 | 2023-10-25 | 칸큐어 엘엘씨 | Mic 항체 및 결합제 및 이의 사용 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2048981B (en) * | 1979-05-23 | 1982-11-17 | Coal Ind | Equipment for laying a layer of elongate material adjacent to an exposed rock or mineral surface in an underground mine |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| CA2158281A1 (en) * | 1993-03-15 | 1994-09-29 | Jay A. Berzofsky | Peptide coated dendritic cells as immunogens |
| US5801005A (en) * | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| US5586538A (en) * | 1995-11-13 | 1996-12-24 | Caterpillar Inc. | Method of correcting engine maps based on engine temperature |
| US6080409A (en) * | 1995-12-28 | 2000-06-27 | Dendreon Corporation | Immunostimulatory method |
| EP0973916A1 (en) * | 1997-04-11 | 2000-01-26 | Dendreon Corporation | Composition and method for inducing an immune response against tumour-related antigens |
| US6194152B1 (en) * | 1997-08-20 | 2001-02-27 | Dendreon Corporation | Prostate tumor polynucleotide compositions and methods of detection thereof |
| EP1141007B1 (en) * | 1998-12-14 | 2013-05-15 | Dendreon Corporation | Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation |
| WO2000044899A1 (en) * | 1999-01-29 | 2000-08-03 | Corixa Corporation | Her-2/neu fusion proteins |
| DK1187629T3 (da) * | 1999-04-19 | 2005-01-17 | Glaxosmithkline Biolog Sa | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid |
| US6406681B1 (en) * | 2000-08-21 | 2002-06-18 | Aeropharm Technology, Inc. | Method of treating a systemic disease |
-
2001
- 2001-03-30 US US09/821,883 patent/US7060279B2/en not_active Expired - Fee Related
- 2001-03-30 DE DE60144516T patent/DE60144516D1/de not_active Expired - Lifetime
- 2001-03-30 EP EP01920913A patent/EP1272633B1/en not_active Expired - Lifetime
- 2001-03-30 AU AU2001247919A patent/AU2001247919B2/en not_active Ceased
- 2001-03-30 AT AT01920913T patent/ATE507295T1/de active
- 2001-03-30 CA CA2403964A patent/CA2403964C/en not_active Expired - Fee Related
- 2001-03-30 AU AU4791901A patent/AU4791901A/xx active Pending
- 2001-03-30 NZ NZ522066A patent/NZ522066A/en not_active IP Right Cessation
- 2001-03-30 DK DK01920913.9T patent/DK1272633T3/da active
- 2001-03-30 PT PT01920913T patent/PT1272633E/pt unknown
- 2001-03-30 WO PCT/US2001/010515 patent/WO2001074855A2/en not_active Ceased
- 2001-03-30 JP JP2001572544A patent/JP5110674B2/ja not_active Expired - Fee Related
- 2001-03-30 ES ES01920913T patent/ES2362715T3/es not_active Expired - Lifetime
-
2005
- 2005-06-03 US US11/144,912 patent/US7659117B2/en not_active Expired - Fee Related
-
2011
- 2011-07-20 CY CY20111100718T patent/CY1111718T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004537252A5 (enExample) | ||
| DE69936784T2 (de) | Behandlung von gebärmutterhalskrebs | |
| JP2004506598A5 (enExample) | ||
| ATE196507T1 (de) | Verfahren zur herstellung von viralen vektoren von mindestens 20kb durch intermolekulare homologe rekombination in einer prokaryotischen zelle | |
| JP2001512748A5 (enExample) | ||
| JP2003510366A5 (enExample) | ||
| WO2000062800A3 (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
| CA2352783A1 (en) | Stimulation of t cells against self antigens using ctla-4 blocking agents | |
| RU2012149618A (ru) | Менингококковые полипептиды fhbp | |
| CN1938044A (zh) | 用于免疫治疗的基于酵母的疫苗 | |
| WO2004067023A3 (en) | Survivin-derived peptides and use thereof | |
| EP1567014A4 (en) | ONE-STEP FAST PROCESS FOR PREPARING AN ANTIGEN-LOADED DENDRIT CELL VACCINE FROM PRE-STEP | |
| JP2003521900A5 (enExample) | ||
| JP2005502314A5 (enExample) | ||
| WO2001023421A3 (en) | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease | |
| JP2001516226A (ja) | 腫瘍関連性の抗原に対する免疫応答を誘導するための組成物および方法 | |
| JP2002534481A5 (enExample) | ||
| DE60319375D1 (de) | Zweifach Coating-beschichteten Milchsäurenbakterienpulver mit Protein und Polysaccharid und das Verfahren zur deren Herstellung sowie deren Dosisform | |
| JP2003530088A5 (enExample) | ||
| WO2002032378A3 (en) | Fusion cells and cytokine compositions for treatment of disease | |
| JP3059482B2 (ja) | 大型多価免疫原 | |
| ATE445015T1 (de) | Verfahren zur herstellung rekombinanter, lipid- modifizierter psaa proteine und deren verwendung | |
| US20070164250A1 (en) | Nanoparticle heating and applications thereof | |
| Xiao et al. | Noninvasive Needle‐Free Cancer Vaccine Cream Patch Based on Fluorinated Chitosan | |
| JP2002522039A5 (enExample) |